id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-E-0943-0007,FDA,FDA-2014-E-0943,TECFIDERA-180 day letter,Other,Directors Determination,2018-04-13T04:00:00Z,2018,4,2018-04-13T04:00:00Z,,2018-04-13T17:09:53Z,,0,0,090000648313c363
FDA-2014-E-0943-0006,FDA,FDA-2014-E-0943,"Determination of Regulatory Review Period for Purposes of Patent
Extension; TECFIDERA",Notice,Determinations,2017-10-05T04:00:00Z,2017,10,2017-10-05T04:00:00Z,2017-12-05T04:59:59Z,2017-10-05T14:47:51Z,2017-21435,0,0,0900006482ba0191
FDA-2014-E-0943-0005,FDA,FDA-2014-E-0943,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2017-06-06T04:00:00Z,2017,6,2017-06-06T04:00:00Z,,2017-06-06T13:22:23Z,,0,0,0900006482696bc0
FDA-2014-E-0943-0004,FDA,FDA-2014-E-0943,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T19:43:29Z,,0,0,09000064824384fd
FDA-2014-E-0943-0003,FDA,FDA-2014-E-0943,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-11-05T05:00:00Z,2015,11,2015-11-05T05:00:00Z,,2015-11-05T14:20:36Z,,0,0,0900006481d14817
FDA-2014-E-0943-0001,FDA,FDA-2014-E-0943,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2014-07-07T04:00:00Z,2014,7,2014-07-07T04:00:00Z,,2014-07-07T19:22:56Z,,0,0,0900006481794ca6
FDA-2014-E-0943-0002,FDA,FDA-2014-E-0943,Patent Extension Application from Sterne Kessler Goldstein and Fox PLLC Biogen Idec International GmbH,Other,Application,2014-07-07T04:00:00Z,2014,7,2014-07-07T04:00:00Z,,2014-07-07T19:23:05Z,,0,0,0900006481794ca8